Mylan working on EpiPen formulation with longer shelf life

Mylan CEO Heather Bresch said Wednesday the company is developing an EpiPen formulation that would extend the shelf life of the product, according to Bloomberg.

Advertisement
By: Mackenzie Bean

The comments were made during her hearing with the House Oversight Committee.

At present, EpiPens have a shelf life of 18 months. The new formulation would boost time between refills to two years.

Ms. Bresch said Canonsburg, Pa.-based Mylan has been working on the reformulation for two years and hopes to submit it to the Food and Drug Administration within days.

More articles on supply chain:

Mylan CEO defends price hikes during heated EpiPen hearing: 5 takeaways
Self-directed robots are the new warehouse workers
Athenahealth CEO: EpiPen price hikes shouldn’t be a political issue

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

  • Abbott launches residual cancer test

    Abbott has launched an updated version of its Oncodetect blood test, which helps clinicians determine whether cancer remains in patients…

    By: Elizabeth Gregerson

  • Supply chain leaders' $1M wish lists

    Becker’s asked supply chain leaders: If you had an extra $1 million for your supply chain budget, where would it…

    By: Ella Jeffries

  • 10 systems seeking supply chain leaders

    As hospitals redefine the role of supply chain leaders to focus on enterprise strategy, digital transformation and resilience, health systems…

    By: Ella Jeffries
Advertisement

Comments are closed.